725 related articles for article (PubMed ID: 22137964)
1. A combination of nonionic surfactants and iontophoresis to enhance the transdermal drug delivery of ondansetron HCl and diltiazem HCl.
Silva SM; Hu L; Sousa JJ; Pais AA; Michniak-Kohn BB
Eur J Pharm Biopharm; 2012 Apr; 80(3):663-73. PubMed ID: 22137964
[TBL] [Abstract][Full Text] [Related]
2. Enhanced in vitro transbuccal drug delivery of ondansetron HCl.
Hu L; Damaj BB; Martin R; Michniak-Kohn BB
Int J Pharm; 2011 Feb; 404(1-2):66-74. PubMed ID: 21056647
[TBL] [Abstract][Full Text] [Related]
3. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
[TBL] [Abstract][Full Text] [Related]
4. Transdermal and transbuccal drug delivery systems: enhancement using iontophoretic and chemical approaches.
Hu L; Silva SM; Damaj BB; Martin R; Michniak-Kohn BB
Int J Pharm; 2011 Dec; 421(1):53-62. PubMed ID: 21963468
[TBL] [Abstract][Full Text] [Related]
5. Non-invasive iontophoretic delivery of enzymatically active ribonuclease A (13.6 kDa) across intact porcine and human skins.
Dubey S; Kalia YN
J Control Release; 2010 Aug; 145(3):203-9. PubMed ID: 20423719
[TBL] [Abstract][Full Text] [Related]
6. Effect of permeation enhancers on the iontophoretic transport of metoprolol tartrate and the drug retention in skin.
Nair A; Vyas H; Shah J; Kumar A
Drug Deliv; 2011 Jan; 18(1):19-25. PubMed ID: 20726811
[TBL] [Abstract][Full Text] [Related]
7. Controlled delivery of ropinirole hydrochloride through skin using modulated iontophoresis and microneedles.
Singh ND; Banga AK
J Drug Target; 2013 May; 21(4):354-66. PubMed ID: 23311703
[TBL] [Abstract][Full Text] [Related]
8. Transdermal iontophoretic delivery of terbinafine hydrochloride: quantitation of drug levels in stratum corneum and underlying skin.
Sachdeva V; Siddoju S; Yu YY; Kim HD; Friden PM; Banga AK
Int J Pharm; 2010 Mar; 388(1-2):24-31. PubMed ID: 20025950
[TBL] [Abstract][Full Text] [Related]
9. Iontophoretic transport kinetics of ketorolac in vitro and in vivo: demonstrating local enhanced topical drug delivery to muscle.
Gratieri T; Pujol-Bello E; Gelfuso GM; de Souza JG; Lopez RF; Kalia YN
Eur J Pharm Biopharm; 2014 Feb; 86(2):219-26. PubMed ID: 23791718
[TBL] [Abstract][Full Text] [Related]
10. Effect of iontophoresis and penetration enhancers on transdermal absorption of metopimazine.
Bounoure F; Lahiani Skiba M; Besnard M; Arnaud P; Mallet E; Skiba M
J Dermatol Sci; 2008 Dec; 52(3):170-7. PubMed ID: 18678472
[TBL] [Abstract][Full Text] [Related]
11. Drug in adhesive type transdermal matrix systems of ondansetron hydrochloride: optimization of permeation pattern using response surface methodology.
Swain K; Pattnaik S; Sahu SC; Patnaik KK; Mallick S
J Drug Target; 2010 Feb; 18(2):106-14. PubMed ID: 19712026
[TBL] [Abstract][Full Text] [Related]
12. Modulated iontophoretic delivery of small and large molecules through microchannels.
Kumar V; Banga AK
Int J Pharm; 2012 Sep; 434(1-2):106-14. PubMed ID: 22633929
[TBL] [Abstract][Full Text] [Related]
13. In vitro permeability of a model protein across ocular tissues and effect of iontophoresis on the transscleral delivery.
Tratta E; Pescina S; Padula C; Santi P; Nicoli S
Eur J Pharm Biopharm; 2014 Sep; 88(1):116-22. PubMed ID: 24816128
[TBL] [Abstract][Full Text] [Related]
14. Microneedle assisted iontophoretic transdermal delivery of prochlorperazine edisylate.
Kolli CS; Xiao J; Parsons DL; Babu RJ
Drug Dev Ind Pharm; 2012 May; 38(5):571-6. PubMed ID: 21980925
[TBL] [Abstract][Full Text] [Related]
15. A statistical approach to the development of a transdermal delivery system for ondansetron.
Obata Y; Ashitaka Y; Kikuchi S; Isowa K; Takayama K
Int J Pharm; 2010 Oct; 399(1-2):87-93. PubMed ID: 20705125
[TBL] [Abstract][Full Text] [Related]
16. In vitro transdermal delivery of caffeine, theobromine, theophylline and catechin from extract of Guarana, Paullinia Cupana.
Heard CM; Johnson S; Moss G; Thomas CP
Int J Pharm; 2006 Jul; 317(1):26-31. PubMed ID: 16600539
[TBL] [Abstract][Full Text] [Related]
17. Novel serine-based gemini surfactants as chemical permeation enhancers of local anesthetics: A comprehensive study on structure-activity relationships, molecular dynamics and dermal delivery.
Teixeira RS; Cova TF; Silva SM; Oliveira R; do Vale ML; Marques EF; Pais AA; Veiga FJ
Eur J Pharm Biopharm; 2015 Jun; 93():205-13. PubMed ID: 25748796
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive transdermal iontophoretic delivery of biologically active human basic fibroblast growth factor.
Dubey S; Perozzo R; Scapozza L; Kalia YN
Mol Pharm; 2011 Aug; 8(4):1322-31. PubMed ID: 21696184
[TBL] [Abstract][Full Text] [Related]
19. The effect of permeation enhancers on the viscosity and the release profile of transdermal hydroxypropyl methylcellulose gel formulations containing diltiazem HCl.
Karakatsani M; Dedhiya M; Plakogiannis FM
Drug Dev Ind Pharm; 2010 Oct; 36(10):1195-206. PubMed ID: 20545504
[TBL] [Abstract][Full Text] [Related]
20. Microemulsions as transdermal drug delivery vehicles.
Kogan A; Garti N
Adv Colloid Interface Sci; 2006 Nov; 123-126():369-85. PubMed ID: 16843424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
